IBEX

AI-powered pathology platform company developing clinical-grade, multi-tissue cancer detection and grading solutions for pathologists, health systems, and diagnostic service providers.

VisitClaim or join

Founded: 2017
Headquarters: Brookline, MA
Company size: Not disclosed
Products tracked: 8

Products by IBEX

8 products

Ibex Breast HER2Platform solution for HER2 analysis within the Ibex Breast Suite.0.00 reviewsDiagnostics & Imaging

Ibex ProstateAI-powered solution for prostate cancer detection and grading; CE marked under IVDR for First Read.0.00 reviewsDiagnostics & Imaging

Ibex BreastAI-powered solution for detecting and grading breast cancer; part of the Ibex Breast Suite.0.00 reviewsDiagnostics & Imaging

Ibex GastricAI-powered solution for gastric cancer detection and grading.0.00 reviewsDiagnostics & Imaging

Ibex BiopharmaSolution supporting biopharma applications on the Ibex platform.0.00 reviewsDiagnostics & Imaging

BiopharmaSeparate offering for biopharma applications.0.00 reviewsDiagnostics & Imaging

Ibex PlatformClinical-grade, multi-tissue AI-powered pathology platform that helps pathologists detect and grade breast, prostate, and gastric cancer along with 100+ clinically relevant feat...0.00 reviewsDiagnostics & Imaging

Ibex Breast SuiteAI-powered breast cancer detection suite, including Ibex Breast and Ibex Breast HER2 solutions.0.00 reviewsDiagnostics & Imaging

Pricing for IBEX

Contact sales

Contact IBEX for current plans, volume pricing, and enterprise terms.

Trust profile

Security and compliance

ISO/IEC 27001

ISO 22301

ISO 9001

Cyber Essentials Plus

HITRUST CSF

CCPA/CPRA

HIPAA

GDPR

Quality Management System (QMS)

CE marked (IVDD)

CE marked under IVDR

UK MHRA registration

ANVISA registration (Brazil)

Research Use Only (RUO) in the United States, not FDA-cleared

Latest updates from IBEX

Jul 232026

New featureCompany news

Ibex Medical Analytics Receives CE-IVDR Certification for Breast Panel IHCs

Ibex Medical Analytics received CE-IVD Medical Devices Regulation (IVDR) certification for its Ibex Breast ER, PR, and Ki67 diagnostic tools. This certification completes the company's breast product portfolio, which now includes fully IVDR-certified end-to-end workflows for H&E and immunohistochemistry (IHC) markers. The suite is designed to automate cell-level quantification and support pathologists in precision oncology by standardizing scores across whole-slide images to help identify patients eligible for targeted breast cancer therapies.

MentionedInstitut Curie